Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo biloba extract 50 tablets for ischemic mild vascular cognitive impairment
ChiCTR2200063158Phase 4Not yet recruiting
- Sponsor
- Shanghai Mental Health Center
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ginkgo biloba extract in vascular cognitive disorder (VCD) (3 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Trail Making Test, Boston Naming Test 2nd Edition and 4 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
ginkgo biloba extract
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on ChiCTR2200063158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063158.